Want to join the conversation?
Pharmaceutical and chemical company $MRK posted 3Q15 GAAP earnings of $0.64 per share vs. $0.31 per share in 3Q14. During the quarter, the company advanced the clinical development program for KEYTRUDA, a drug approved by the FDA for the treatment of advanced melanoma and metastatic NSCLC.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!